How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
On February 5, 2026, OpenAI introduced GPT-5.3-Codex and wrote in its release notes that early versions of the model were ā€œinstrumental in creating itself,ā€ helping to debug training runs, manage ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Abstract: The letter suggests utilizing a recursive-least-squares identification algorithm for real-time estimation of supercapacitor equivalent capacitance and resistance. Estimation is required ...
Abstract: This paper studies the estimation of dynamic route choice behavior of drivers with incomplete fixed location-based sensor data, such as radio frequency identification (RFID) data. Unlike ...
The DHI MATLAB Toolbox provides a number of tools and examples for working with DHI related data files within MATLAB. The current version of the toolbox supports reading of all dfs file types, ...
This toolbox brings robotics specific functionality to MATLAB, exploiting the native capabilities of MATLAB (linear algebra, portability, graphics). The Toolbox uses a very general method of ...